All In Biotech

Free tool

FAERS Monitor: Neffy

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214697 or its brand name (Neffy, Epinephrine). Reports on generic versions are filed under their own applications.

Reports

42,517

Serious

26,368

62% of reports

Hospitalization

14,004

Death reported

3,545

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,560
  • headache3,091
  • sinusitis2,920
  • fatigue2,804
  • product dose omission issue2,783
  • pain2,492
  • covid-192,424
  • dyspnoea2,275
  • nausea2,238
  • pneumonia2,076
  • off label use2,072
  • inappropriate schedule of product administration1,785
  • nasopharyngitis1,685
  • pyrexia1,658
  • urinary tract infection1,591

Reports by year received

View as table
YearReports
2004133
2005118
2006136
2007166
2008194
2009269
2010261
2011702
2012425
2013301
2014411
2015635
20161,057
20171,572
20182,477
20193,337
20206,460
20213,909
20223,582
20233,781
20244,436
20254,805
20263,347

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,642 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
sinusitisSignal2,92014.514.035,757
covid-19Signal2,4246.96.712,195
inappropriate schedule of product administrationSignal1,7854.94.75,595
product dose omission issueSignal2,7834.74.58,185
urinary tract infectionSignal1,5914.64.44,546
nasopharyngitisSignal1,6854.64.34,669
pneumoniaSignal2,0763.23.13,140
headacheSignal3,0912.42.42,709
pyrexiaSignal1,6582.42.31,337
painSignal2,4922.01.91,298
dyspnoea2,2752.01.91,149
fatigue2,8041.81.71,000
drug ineffective4,5601.71.71,442
nausea2,2381.41.3265
off label use2,0721.21.154

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.